Statistics
Publications
6
Citations
321
H-Index
6
Active since
2019
Affiliations
Xueli Fu is an author at Nankai University specializing in oncology, molecular oncology, and pharmacology.
Publications per year
2019–2025
6
6
Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma
Lu Zhang, Xian-meng Li, Xu-he Shi et al. · Acta Pharmacologica Sinica · 2022 · 87 citations · Full text
Medicine, Oncology, Pharmacology +16
The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth
Feifei Xu, Huimin Sun, Runping Fang et al. · Acta Pharmacologica Sinica · 2021 · 22 citations · Full text
Medicine, Cancer Biology, Oncology +14
1–5 of 6